Keywords: fda, approves, gemzar, nsc, lung, cancer, eli

FDA Approves Gemzar For NSC Lung Cancer

Article | 27 August 1998

Print This

Eli Lilly's Gemzar (gemcitabine HCl) has been given approval by the USFood and Drug Administration for the additional indication of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in